TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9188991

Group type: EXPERIMENTAL
Intervention: Trackball operation with free head movements
Number of subjects: 18

Group type: COMPARATOR
Intervention: Trackball operation with fixed head (using only jaw muscles)
Number of subjects: 18
Study: 1336762

Group type: EXPERIMENTAL
Intervention: Oral itraconazole 200 mg daily for five days, then 200 mg twice weekly for six months
Number of subjects: 44

Group type: COMPARATOR
Intervention: Intravaginal clotrimazole 200 mg ovules daily for five days, then 200 mg twice weekly for six months
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Oral itraconazole after discontinuation of therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Intravaginal clotrimazole after discontinuation of therapy
Number of subjects: 44
Study: 3799209

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 0.5 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 31016503

Group type: EXPERIMENTAL
Intervention: Condom videos
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Peer norms growth trajectories
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Self-efficacy growth trajectories
Number of subjects: 804

Group type: EXPERIMENTAL
Intervention: Condom use behavior growth trajectories
Number of subjects: 804
Study: 29230665

Group type: EXPERIMENTAL
Intervention: 5 years of extended letrozole
Number of subjects: 1824

Group type: COMPARATOR
Intervention: 2.5 years of extended letrozole
Number of subjects: 1824
Study: 27395054

Group type: EXPERIMENTAL
Intervention: 45-kg thoracic loading
Number of subjects: 19

Group type: COMPARATOR
Intervention: Unloaded condition
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 15 kg load
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 30 kg load
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 45 kg load
Number of subjects: 19
Study: 24901386

Group type: EXPERIMENTAL
Intervention: PAH-related hospitalization
Number of subjects: 862

Group type: EXPERIMENTAL
Intervention: PAH-unrelated hospitalization
Number of subjects: 862
Study: 22248375

Group type: EXPERIMENTAL
Intervention: Bizarre sentences presented to young and older adults under incidental recall conditions in Experiment 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bizarre sentences presented to young and older adults under intentional learning conditions in Experiment 2
Number of subjects: 0
Study: 21313929

Group type: EXPERIMENTAL
Intervention: Vicarious audiovisual learning (video)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Text learning (control)
Number of subjects: 37
Study: 18345398

Group type: EXPERIMENTAL
Intervention: Cilazapril alone or cilazapril/hydrochlorothiazide/amlodipine combination therapy
Number of subjects: 49
Study: 16223944

Group type: EXPERIMENTAL
Intervention: Cystic fibrosis patients' intestinal biopsies
Number of subjects: 12
Study: 14561263

Group type: EXPERIMENTAL
Intervention: InSure test (brush-based faecal immunochemical test)
Number of subjects: 46

Group type: COMPARATOR
Intervention: FlexSure OBT test (traditional spatula-sampling immunochemical test)
Number of subjects: 46
Study: 10626972

Group type: EXPERIMENTAL
Intervention: Lateral thoracodorsal flap
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Latissimus dorsi flap
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: TRAM flap
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All methods
Number of subjects: 75
Study: 9366768

Group type: EXPERIMENTAL
Intervention: Sodium citrate
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sodium heparin, EDTA, lithium heparin
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Plasma and serum samples
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Plasma vs. whole blood
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Serum vs. plasma
Number of subjects: 42
Study: 1567264

Group type: EXPERIMENTAL
Intervention: Diminazene aceturate (Berenyl)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Cetrimide 15% + chlorhexidine 1.5% (Savlon)
Number of subjects: 66
Study: 3935455

Group type: EXPERIMENTAL
Intervention: Metolazone (2.5 mg orally after 6 hours of furosemide infusion)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Furosemide (4 mg h‐1 intravenous infusion for 12 hours)
Number of subjects: 8
Study: 30379387

Group type: EXPERIMENTAL
Intervention: Cathodal transcranial direct current stimulation (tDCS) over right Broca's area
Number of subjects: 0

Group type: COMPARATOR
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 30082326

Group type: EXPERIMENTAL
Intervention: Exenatide QW (2-mg subcutaneous injection) plus dapagliflozin (10-mg oral tablet)
Number of subjects: 695

Group type: COMPARATOR
Intervention: Exenatide QW (2-mg subcutaneous injection)
Number of subjects: 695

Group type: COMPARATOR
Intervention: Dapagliflozin (10-mg oral tablet)
Number of subjects: 695
Study: 27923401

Group type: EXPERIMENTAL
Intervention: WHO Safe Childbirth Checklist (SCC) embedded in a quality improvement program, including leadership engagement, a 2-day educational launch, and support from a trained peer coach over an 8-month period.
Number of subjects: 171964

Group type: EXPERIMENTAL
Intervention: WHO Safe Childbirth Checklist (SCC)
Number of subjects: 171964

Group type: COMPARATOR
Intervention: Control group (60 sites without the SCC intervention)
Number of subjects: 171964
Study: 24780614

Group type: EXPERIMENTAL
Intervention: Eplerenone (25-50 mg once daily)
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1012
Study: 21862447

Group type: EXPERIMENTAL
Intervention: Word listening task with auditory stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Younger adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Middle-aged adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 0
Study: 19579199

Group type: EXPERIMENTAL
Intervention: BioGlue™ for mesh fixation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional suture for mesh fixation
Number of subjects: 60
Study: 17846938

Group type: EXPERIMENTAL
Intervention: Integrated primary care model for COPD
Number of subjects: 260

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 260
Study: 15084974

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 42

Group type: COMPARATOR
Intervention: Radiochemotherapy
Number of subjects: 42
Study: 11395821

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy (LA)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Open appendectomy (OA)
Number of subjects: 106
Study: 9755021

Group type: EXPERIMENTAL
Intervention: Ultrasound, massage and exercise (group A)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Sham-ultrasound, massage and exercise (group B)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (group C)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 58

Group type: COMPARATOR
Intervention: Treatment groups (A and B) vs Control group (C)
Number of subjects: 58
Study: 8116577

Group type: EXPERIMENTAL
Intervention: Thin-layer processing device
Number of subjects: 3218

Group type: COMPARATOR
Intervention: Conventional smear
Number of subjects: 3218
Study: 3041785

Group type: EXPERIMENTAL
Intervention: Terodiline hydrochloride (24 mg/day)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Flavoxate hydrochloride (600 mg/day)
Number of subjects: 199
Study: 30669199

Group type: EXPERIMENTAL
Intervention: 1/3 octave
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1/12 octave
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1/24 octave
Number of subjects: 90
Study: 28292867

Group type: EXPERIMENTAL
Intervention: Thrombectomy with Solitaire FR Device
Number of subjects: 206

Group type: COMPARATOR
Intervention: Best Medical Therapy (Control)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 206
Study: 26620188

Group type: EXPERIMENTAL
Intervention: Action or Maintenance stages
Number of subjects: 504

Group type: COMPARATOR
Intervention: Precontemplation stage
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Maintenance stage
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: All stages
Number of subjects: 504
Study: 22789872

Group type: EXPERIMENTAL
Intervention: Sexual healthcare education program (12-week duration)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 190
Study: 21944653

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (12 sessions of 30 minutes each)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group (standard rehabilitation without acupuncture)
Number of subjects: 93
Study: 20078940

Group type: COMPARATOR
Intervention: 2827C>T polymorphism in the prostasin gene
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: E342K mutation in the prostasin gene
Number of subjects: 938
Study: 16376092

Group type: EXPERIMENTAL
Intervention: Intracoronary shunt
Number of subjects: 40

Group type: COMPARATOR
Intervention: Shuntless anastomosis
Number of subjects: 40
Study: 15223882

Group type: EXPERIMENTAL
Intervention: High-resistance training (HT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Moderate-resistance training (MT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study: 11475801

Group type: EXPERIMENTAL
Intervention: Therapeutic Drug Monitoring (TDM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Target Concentration Intervention (TCI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomised Concentration Controlled Trials (RCCT)
Number of subjects: 0
Study: 9250283

Group type: EXPERIMENTAL
Intervention: IFN + UDCA
Number of subjects: 41

Group type: COMPARATOR
Intervention: IFN
Number of subjects: 41
Study: 8490549

Group type: EXPERIMENTAL
Intervention: Mammographic screening
Number of subjects: 0
Study: 3557003

Group type: COMPARATOR
Intervention: Indomethacin (50 mg oral doses for 4 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Indomethacin (100 mg single oral dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31329610

Group type: EXPERIMENTAL
Intervention: MERM device with daily alert and scheduled dosing history review
Number of subjects: 20

Group type: COMPARATOR
Intervention: MERM device without an alert
Number of subjects: 20
Study: 28684083

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with extra-virgin olive oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with mixed-nuts
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 26082623

Group type: EXPERIMENTAL
Intervention: Treatment with long-acting anticholinergic drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Concomitant systemic corticosteroids for the current exacerbation
Number of subjects: 0
Study: 23515006

Group type: EXPERIMENTAL
Intervention: DHA supplementation (1.16 g DHA/d)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 21242737

Group type: EXPERIMENTAL
Intervention: PHMB foam dressing
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (non-antimicrobial foam)
Number of subjects: 45
Study: 18188660

Group type: EXPERIMENTAL
Intervention: aerobic exercise + home exercise
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: physical therapy (hot pack, ultrasound, TENS) + home exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: home exercise only
Number of subjects: 60
Study: 16869219

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 12923829

Group type: EXPERIMENTAL
Intervention: Diazepam (12 or 18 mg/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Diazepam (6 mg/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 11100393

Group type: EXPERIMENTAL
Intervention: Low-dose adrenomedullin (ADM, 1, 2 and 3 pmol kg‐1 min‐1 for 30 min each)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 8874298

Group type: EXPERIMENTAL
Intervention: Patients treated in 1988 to 1990 with three or more organ system failures on day 4 or later of organ system failure
Number of subjects: 17440

Group type: EXPERIMENTAL
Intervention: Patients treated in 1988 to 1990
Number of subjects: 17440

Group type: COMPARATOR
Intervention: Patients treated in 1979 to 1982
Number of subjects: 17440

Group type: EXPERIMENTAL
Intervention: Prognostic scoring system on day 1 of organ system failure
Number of subjects: 17440

Group type: EXPERIMENTAL
Intervention: Model based on the number of organ system failures
Number of subjects: 17440
Study: 1445824

Group type: EXPERIMENTAL
Intervention: Meals based on steam-cooked semolina
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meals based on semolina-Bengal gram dhal
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meals based on semolina-black gram dhal
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional Indian meals (various types)
Number of subjects: 30
Study: 3901956

Group type: EXPERIMENTAL
Intervention: Bilateral electroconvulsive therapy (ECT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nondominant unilateral electroconvulsive therapy (ECT)
Number of subjects: 48
Study: 29926979

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri 6475 (1010 colony-forming units daily)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 27689192

Group type: EXPERIMENTAL
Intervention: Split-dose regimen of sodium picosulfate/magnesium citrate (SPMC)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Prior-day schedule (AM/PM)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Both regimens
Number of subjects: 315
Study: 25362223

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin (enoxaparin), 0.5 mg/kg at the beginning of each hemodialysis session
Number of subjects: 58

Group type: COMPARATOR
Intervention: Unfractionated heparin (UF heparin), 5000 units
Number of subjects: 58
Study: 22647278

Group type: EXPERIMENTAL
Intervention: Jumping exercise intervention (supervised jumping protocol during the first 10 min of physical education class, twice a week for 9 months)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (completed regular curriculum)
Number of subjects: 43
Study: 20306185

Group type: EXPERIMENTAL
Intervention: Metronidazole 500 mg three times daily for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17852012

Group type: EXPERIMENTAL
Intervention: Timed Up and Go (TUG) test
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: TUG test
Number of subjects: 31
Study: 16051944

Group type: EXPERIMENTAL
Intervention: FU/DOX
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: FU/STZ
Number of subjects: 249

Group type: COMPARATOR
Intervention: DTIC
Number of subjects: 249
Study: 12392445

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy (ESWT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo ESWT
Number of subjects: 0
Study: 11195609

Group type: EXPERIMENTAL
Intervention: Telmisartan 80 mg/HCTZ 12.5 mg
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg/HCTZ 12.5 mg
Number of subjects: 222
Study: 9934058

Group type: EXPERIMENTAL
Intervention: Continuous enteral nutrition without interruption (WI)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Enteral nutrition with a 7-hour nightly rest (NR)
Number of subjects: 69
Study: 7880215

Group type: EXPERIMENTAL
Intervention: 0.5 MAC of isoflurane
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 0.5 MAC of isoflurane + 0.6 MAC of N2O
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1.1 MAC of isoflurane + 0.6 MAC of N2O
Number of subjects: 6

Group type: COMPARATOR
Intervention: 1.1 MAC of isoflurane
Number of subjects: 6
Study: 3047920

Group type: EXPERIMENTAL
Intervention: 75 mg of iron per day, as ferrous gluconate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Calcium phosphate placebo
Number of subjects: 0
Study: 29380821

Group type: EXPERIMENTAL
Intervention: Gluten (10 g/daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (rice starch)
Number of subjects: 36
Study: 28323305

Group type: EXPERIMENTAL
Intervention: Exercise Intervention (EI)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Wait-list Control (WLC)
Number of subjects: 49
Study: 25079374

Group type: EXPERIMENTAL
Intervention: 1,2‐(13) C‐DCA
Number of subjects: 17
Study: 23292034

Group type: EXPERIMENTAL
Intervention: Liquid formula
Number of subjects: 78

Group type: COMPARATOR
Intervention: Powdered formula
Number of subjects: 78
Study: 21823173

Group type: EXPERIMENTAL
Intervention: Alcohol at 0.05% BAC
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Alcohol at 0.08% BAC
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Alcohol at 0.11% BAC
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo-alcohol
Number of subjects: 27
Study: 18362301

Group type: EXPERIMENTAL
Intervention: Low-caloric diet (LCD; 600 kcal/d less than energy requirements)
Number of subjects: 40
Study: 17157575

Group type: EXPERIMENTAL
Intervention: LASEK
Number of subjects: 122

Group type: COMPARATOR
Intervention: LASIK
Number of subjects: 122
Study: 12712084

Group type: EXPERIMENTAL
Intervention: Pipelle biopsy
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Frozen section
Number of subjects: 32
Study: 11061197

Group type: EXPERIMENTAL
Intervention: Trans-tibial amputees (TTA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study: 8607960

Group type: EXPERIMENTAL
Intervention: loratadine (10 mg by mouth daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: terfenadine (60 mg by mouth twice daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: loratadine and terfenadine
Number of subjects: 14
Study: 1443846

Group type: EXPERIMENTAL
Intervention: One minute of TENS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ten minutes of TENS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 20 minutes of TENS
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 15
Study: 31170114

Group type: EXPERIMENTAL
Intervention: Home biofeedback
Number of subjects: 100

Group type: COMPARATOR
Intervention: Office biofeedback
Number of subjects: 100
Study: 30183102

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 5234

Group type: COMPARATOR
Intervention: Control (placebo/ezetimibe)
Number of subjects: 5234
Study: 27323555

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF) after separation from CPB
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no MUF)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration (MUF)
Number of subjects: 80
Study: 24103462

Group type: EXPERIMENTAL
Intervention: Nasolabial flap (Group I, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Buccal fat pad (BFP) (Group II, n = 10)
Number of subjects: 20
Study: 23477161

Group type: EXPERIMENTAL
Intervention: Maixuekang capsule combined with conventional therapy for 3 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 120
Study: 29648531

Group type: EXPERIMENTAL
Intervention: Propafenone (300 mg tablet)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ritmonorm® (300 mg tablet)
Number of subjects: 0
Study: 17288686

Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Desloratadine 7.5 mg plus alcohol (0.1% BAC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo plus alcohol (0.1% BAC)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Desloratadine 7.5 mg vs. placebo with alcohol
Number of subjects: 25
Study: 15664577

Group type: EXPERIMENTAL
Intervention: Reduced tube current settings (60‐75, 76‐90, and 91‐130 mA for thoracic, abdominal, and pelvic examinations; 76‐90 and 91‐130 mA for cranial examinations)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional tube current settings (180‐240 mA)
Number of subjects: 0
Study: 12140664

Group type: EXPERIMENTAL
Intervention: Flupirtine 50 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Flupirtine 100 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 9987141

Group type: EXPERIMENTAL
Intervention: Adjuvanted influenza vaccine (FLUAD, Chiron Vaccines)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional non-adjuvanted influenza vaccine
Number of subjects: 92
Study: 7762525

Group type: EXPERIMENTAL
Intervention: 100 mg beta-carotene/d for 6 d as synthetic all-trans-beta-carotene
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Natural beta-carotene preparation (50:50 mixture of all-trans- and 6-cis-beta-carotene)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 50 mg all-trans-beta-carotene or either 66 or 100 mg of the natural 50:50 isomeric mixture (alternate-day supplementation for 23 d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 24
Study: 2405112

Group type: EXPERIMENTAL
Intervention: Education plus additional motivational intervention (feedback about exhaled CO values, spirometry results, and pulmonary symptoms)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Education plus additional motivational intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Education alone (control group)
Number of subjects: 90
Study: 6101792

Group type: EXPERIMENTAL
Intervention: Periconceptional multivitamin supplementation
Number of subjects: 438

Group type: COMPARATOR
Intervention: Unsupplemented mothers
Number of subjects: 438
Study: 30738021

Group type: EXPERIMENTAL
Intervention: Teen Online Problem‐Solving‐Teen Only (TOPS‐TO)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Teen Online Problem‐Solving with Family (TOPS‐F)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Internet resource comparison (IRC)
Number of subjects: 152
Study: 28687348

Group type: EXPERIMENTAL
Intervention: LOVED program (interactive web-based app with video education modules and group video chat sessions)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LOVED program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 60